Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia [IMMUNOTHERAPY AND VACCINES] - Aue, G., Sun, C., Liu, D., Park, J.-H., Pittaluga, S., Tian, X., Lee, E., Soto, S., Valdez, J., Maric, I., Stetler-Stevenson, M., Yuan, C., Nakamura, Y., Muranski, P., Wiestner, A. (The American Association of Immunologists (AAI), 2018)
6333394
Keywords: WW-YZ